trending Market Intelligence /marketintelligence/en/news-insights/trending/9zdnvtzgaqvtsi66j052qa2 content esgSubNav
In This List

Biocept completes rights offering to raise $10.4M

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Biocept completes rights offering to raise $10.4M

Biocept Inc. completed a rights offering to raise about $10.4 million in net proceeds.

The San Diego-based company sold 11,587 units consisting of 11,587 shares of series A preferred stock and 2,549,140 warrants, with each warrant exercisable for one common stock at $4.53 per share.

Maxim Group LLC and Dawson James Securities Inc. acted as co-dealer-managers for the offering.

Biocept is a molecular diagnostics company that provides assays for lung, breast, gastric, colorectal, prostate and skin cancers.